203 related articles for article (PubMed ID: 23341910)
1. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).
Sullivan AK; Raben D; Reekie J; Rayment M; Mocroft A; Esser S; Leon A; Begovac J; Brinkman K; Zangerle R; Grzeszczuk A; Vassilenko A; Hadziosmanovic V; Krasnov M; Sönnerborg A; Clumeck N; Gatell J; Gazzard B; Monforte Ad; Rockstroh J; Lundgren JD
PLoS One; 2013; 8(1):e52845. PubMed ID: 23341910
[TBL] [Abstract][Full Text] [Related]
2. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
Raben D; Sullivan AK; Mocroft A; Kutsyna G; Hadžiosmanović V; Vassilenko A; Chkhartisvili N; Mitsura V; Pedersen C; Anderson J; Begovac J; Bak Dragsted U; Bertisch B; Grzeszczuk A; Minton J; Necsoi VC; Kitchen M; Ajana F; Sokhan A; Comi L; Farazmand P; Pesut D; De Wit S; Gatell JM; Gazzard B; d'Arminio Monforte A; Rockstroh JK; Yazdanpanah Y; Champenois K; Jakobsen ML; Lundgren JD;
PLoS One; 2019; 14(8):e0220108. PubMed ID: 31408476
[TBL] [Abstract][Full Text] [Related]
3. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
Raben D; Mocroft A; Rayment M; Mitsura VM; Hadziosmanovic V; Sthoeger ZM; Palfreeman A; Morris S; Kutsyna G; Vassilenko A; Minton J; Necsoi C; Estrada VP; Grzeszczuk A; Johansson VS; Begovac J; Ong EL; Cabié A; Ajana F; Celesia BM; Maltez F; Kitchen M; Comi L; Dragsted UB; Clumeck N; Gatell J; Gazzard B; d'Arminio Monforte A; Rockstroh J; Yazdanpanah Y; Champenois K; Jakobsen ML; Sullivan A; Lundgren JD;
PLoS One; 2015; 10(11):e0140845. PubMed ID: 26560105
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.
Scognamiglio P; Chiaradia G; De Carli G; Giuliani M; Mastroianni CM; Aviani Barbacci S; Buonomini AR; Grisetti S; Sampaolesi A; Corpolongo A; Orchi N; Puro V; Ippolito G; Girardi E;
BMC Infect Dis; 2013 Oct; 13():473. PubMed ID: 24112129
[TBL] [Abstract][Full Text] [Related]
5. The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
Tominski D; Katchanov J; Driesch D; Daley MB; Liedtke A; Schneider A; Slevogt H; Arastéh K; Stocker H
HIV Med; 2017 Feb; 18(2):125-132. PubMed ID: 27478058
[TBL] [Abstract][Full Text] [Related]
6. [Indicator condition guided human immunodeficiency virus requesting in primary health care: results of a collaboration].
Cayuelas-Redondo L; Menacho-Pascual I; Noguera-Sánchez P; Goicoa-Gago C; Pollio-Peña G; Blanco-Delgado R; Barba-Ávila O; Sequeira-Aymar E; Muns M; Clusa T; García F; León A
Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):656-62. PubMed ID: 25769383
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions.
Menacho I; Sequeira E; Muns M; Barba O; Leal L; Clusa T; Fernandez E; Moreno L; Raben D; Lundgren J; Gatell JM; Garcia F; Cayuelas L; Aragunde V; Vergara M; Catalan M; Moreno MA; Hormigo G; Siso A; Herreras Z; Sebastian L; Benito L; Picas A; Hoyo J; Giner MJ; Cararach D; Moles E; Moro ML; Arrabal P; Roca D; Prego S; Ferrer X; Egido A; Ventosa C; Garcia S; Muñoz S; Massana A; Sole J; Curiel M; Heras F; Leon A
HIV Med; 2013 Oct; 14 Suppl 3():33-7. PubMed ID: 24033901
[TBL] [Abstract][Full Text] [Related]
8. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
9. High linkage to care in a community-based rapid HIV testing and counseling project among men who have sex with men in Copenhagen.
Qvist T; Cowan SA; Graugaard C; Helleberg M
Sex Transm Dis; 2014 Mar; 41(3):209-14. PubMed ID: 24521728
[TBL] [Abstract][Full Text] [Related]
10. The case for indicator condition-guided HIV screening.
Lazarus JV; Hoekstra M; Raben D; Delpech V; Coenen T; Lundgren JD;
HIV Med; 2013 Aug; 14(7):445-8. PubMed ID: 23480600
[TBL] [Abstract][Full Text] [Related]
11. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
; Mocroft A; Lundgren J; Antinori A; Monforte Ad; Brännström J; Bonnet F; Brockmeyer N; Casabona J; Castagna A; Costagliola D; De Wit S; Fätkenheuer G; Furrer H; Jadand C; Johnson A; Lazanas M; Leport C; Moreno S; Mussini C; Obel N; Post F; Reiss P; Sabin C; Skaletz-Rorowski A; Suarez-Loano I; Torti C; Warszawski J; Wittkop L; Zangerle R; Chene G; Raben D; Kirk O
Euro Surveill; 2015; 20(47):. PubMed ID: 26624933
[TBL] [Abstract][Full Text] [Related]
12. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
Lin YD; Garner SE; Lau JSY; Korman TM; Woolley IJ
QJM; 2019 Jan; 112(1):17-21. PubMed ID: 30295832
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa.
Regan S; Losina E; Chetty S; Giddy J; Walensky RP; Ross D; Holst H; Katz JN; Freedberg KA; Bassett IV
PLoS One; 2013; 8(4):e62362. PubMed ID: 23626808
[TBL] [Abstract][Full Text] [Related]
15. Monitoring HIV-indicator condition guided HIV testing in Estonia.
Rüütel K; Lemsalu L; Lätt S;
HIV Med; 2018 Feb; 19 Suppl 1():47-51. PubMed ID: 29488700
[TBL] [Abstract][Full Text] [Related]
16. COBA-Cohort: a prospective cohort of HIV-negative men who have sex with men, attending community-based HIV testing services in five European countries (a study protocol).
Lorente N; Fernàndez-López L; Fuertes R; Rojas Castro D; Pichon F; Cigan B; Chanos S; Meireles P; Lucas R; Morel S; Slaaen Kaye P; Agustí C; Klavs I; Platteau T; Casabona J;
BMJ Open; 2016 Jul; 6(7):e011314. PubMed ID: 27412103
[TBL] [Abstract][Full Text] [Related]
17. Actual and undiagnosed HIV prevalence in a community sample of men who have sex with men in Auckland, New Zealand.
Saxton PJ; Dickson NP; Griffiths R; Hughes AJ; Rowden J
BMC Public Health; 2012 Feb; 12():92. PubMed ID: 22296737
[TBL] [Abstract][Full Text] [Related]
18. Choice of Rapid HIV testing and entrance into care in Baltimore City sexually transmitted infections clinics.
Keller S; Jones J; Erbelding E
AIDS Patient Care STDS; 2011 Apr; 25(4):237-43. PubMed ID: 21395433
[TBL] [Abstract][Full Text] [Related]
19. Acceptability, feasibility and impact of routine screening to detect undiagnosed HIV infection in 17 - 24-month-old children in the western sub-district of Cape Town.
Levin M; Mathema H; Stinson K; Jennings K
S Afr Med J; 2012 Mar; 102(4):245-8. PubMed ID: 22464508
[TBL] [Abstract][Full Text] [Related]
20. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: a serial cross-sectional study.
Aghaizu A; Wayal S; Nardone A; Parsons V; Copas A; Mercey D; Hart G; Gilson R; Johnson AM
Lancet HIV; 2016 Sep; 3(9):e431-e440. PubMed ID: 27562744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
